FDA Proposes New Approval Pathway for Rare Disease Gene Therapy

(MedPage Today) — The FDA on Monday unveiled draft guidance for a new “plausible mechanism” approval pathway for ultra-rare disease treatments.
“What is a ‘plausible mechanism’ pathway? It’s common sense,” FDA Commissioner Marty Makary, MD, MPH…